Modulating effects of Astragalus polysaccharide on immune disorders via gut microbiota and the TLR4/NF-κB pathway in rats with syndrome of dampness stagnancy due to spleen deficiency
The syndrome of dampness stagnancy due to spleen deficiency (DSSD) is relatively common globally. Although the pathogenesis of DSSD remains unclear, evidence has suggested that the gut microbiota might play a significant role. Radix Astragali , used as both medicine and food, exerts the effects of t...
Saved in:
Published in | Journal of Zhejiang University. B. Science Vol. 24; no. 7; pp. 650 - 662 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hangzhou
Zhejiang University Press
01.07.2023
Springer Nature B.V School of Nursing,Shandong University of Traditional Chinese Medicine,Jinan 250355,China%College of Traditional Chinese Medicine,Shandong Co-Innovation Center of Classic Traditional Chinese Medicine Formula,Shandong University of Traditional Chinese Medicine,Jinan 250355,China%School of Pharmaceutical Sciences,Cheeloo College of Medicine,Shandong University,Jinan 250012,China |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The syndrome of dampness stagnancy due to spleen deficiency (DSSD) is relatively common globally. Although the pathogenesis of DSSD remains unclear, evidence has suggested that the gut microbiota might play a significant role.
Radix Astragali
, used as both medicine and food, exerts the effects of tonifying spleen and qi.
Astragalus
polysaccharide (APS) comprises a macromolecule substance extracted from the dried root of
Radix Astragali
, which has many pharmacological functions. However, whether APS mitigates the immune disorders underlying the DSSD syndrome via regulating gut microbiota and the relevant mechanism remains unknown. Here, we used DSSD rats induced by high-fat and low-protein (HFLP) diet plus exhaustive swimming, and found that APS of moderate molecular weight increased the body weight gain and immune organ indexes, decreased the levels of interleukin-1β (IL-1β), IL-6, and endotoxin, and suppressed the Toll-like receptor 4/nuclear factor-κB (TLR4/NF-κB) pathway. Moreover, a total of 27 critical genera were significantly enriched according to the linear discriminant analysis effect size (LEfSe). APS increased the diversity of the gut microbiota and changed its composition, such as reducing the relative abundance of
Pseudoflavonifractor
and
Paraprevotella
, and increasing that of
Parasutterella
,
Parabacteroides
,
Clostridium XIVb
,
Oscillibacter
,
Butyricicoccus
, and
Dorea
. APS also elevated the contents of short-chain fatty acids (SCFAs). Furthermore, the correlation analysis indicated that 12 critical bacteria were related to the body weight gain and immune organ indexes. In general, our study demonstrated that APS ameliorated the immune disorders in DSSD rats via modulating their gut microbiota, especially for some bacteria involving immune and inflammatory response and SCFA production, as well as the TLR4/NF-κB pathway. This study provides an insight into the function of APS as a unique potential prebiotic through exerting systemic activities in treating DSSD. |
---|---|
Bibliography: | Haijun ZHAO, https://orcid.org/0000-0003-0858-7486 Wenxiao ZHAO, https://orcid.org/0000-0001-7165-5870 |
ISSN: | 1673-1581 1862-1783 |
DOI: | 10.1631/jzus.B2200491 |